Flunisan (Fluoxetine) 20mg is a selective serotonin reuptake inhibitors (SSRI) antidepressant. The way Flunisan works is still not fully understood. It is thought to positively affect communication between nerve cells in the central nervous system and/or restore chemical balance in the brain. Flunisan (Fluoxetine) 20mg is used to treat major depressive disorder, bulimia nervosa (an eating disorder) obsessive-compulsive disorder, and panic disorder.
Flunisan (Fluoxetine) 20mg is sometimes used together with another medication called olanzapine (Zyprexa). to treat depression caused by bipolar disorder (manic depression). This combination is also used to treat depression after at least 2 other medications have been tried without successful treatment of symptoms.
Flunisan (Fluoxetine) 20mg is used to treat depression, panic attacks, obsessive compulsive disorder, a certain eating disorder (bulimia), and a severe form of premenstrual syndrome (premenstrual dysphoric disorder).
Flunisan (Fluoxetine) 20mg may improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living. It may decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. It may also reduce the urge to perform repeated tasks (compulsions such as hand-washing, counting, and checking) that interfere with daily living. Flunisan (Fluoxetine) 20mg may lessen premenstrual symptoms such as irritability, increased appetite, and depression. It may decrease binging and purging behaviors in bulimia.
- Major Depressive Disorder: Flunisan (Fluoxetine) 20mg is indicated for the acute and maintenance treatment of Major Depressive Disorder in adult patients and in pediatric patients aged 8 to 18 years. The usefulness of the drug in adult and pediatric patients receiving Flunisan for extended periods should periodically be re-evaluated.
- Obsessive Compulsive Disorder: Flunisan (Fluoxetine) 20mg is indicated for the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with Obsessive Compulsive Disorder (OCD). The effectiveness of Flunisan in long-term use, i.e., for more than 13 weeks, has not been systematically evaluated in placebo-controlled trials. Therefore, the physician who elects to use Flunisan for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.
- Bulimia Nervosa: Flunisan (Fluoxetine) 20mg is indicated for the acute and maintenance treatment of binge-eating and vomiting behaviors in adult patients with moderate to severe Bulimia Nervosa. The physician who elects to use Flunisan for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.
- Panic Disorder: Flunisan (Fluoxetine) 20mg is indicated for the acute treatment of Panic Disorder, with or without agoraphobia, in adult patients. The effectiveness of Flunisan in long-term use, i.e., for more than 12 weeks, has not been established in placebo-controlled trials. Therefore, the physician who elects to use Flunisan for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.
Use Flunisan delayed-release capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- Flunisan (Fluoxetine) 20mg delayed-release capsules comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Flunisan delayed-release capsules refilled.
- Take Flunisan (Fluoxetine) 20mg delayed-release capsules by mouth with or without food.
- Swallow Flunisan delayed-release capsules whole. Do not break, crush, or chew before swallowing.
- Taking Flunisan (Fluoxetine) 20mg delayed-release capsules at the same time each day will help you remember to take it.
- Continue to take Flunisan delayed-release capsules even if you feel well. Do not miss any doses.
- Do not suddenly stop taking Flunisan delayed-release capsules without checking with your doctor. Side effects may occur. They may include mental or mood changes, numbness or tingling of the skin, dizziness, confusion, headache, trouble sleeping, or unusual tiredness. You will be closely monitored when you start Flunisan delayed-release capsules and whenever a change in dose is made.
- If you miss a dose of Flunisan delayed-release capsules, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.
Possible side effect
- From the side of the central nervous system: increased suicidal tendencies, anxiety, headache, tremor, agitation, increased irritability, sleep disturbance, dizziness, drowsiness, asthenic disorders, mania or hypomania, seizures.
- From the side of the digestive system: nausea, diarrhea, vomiting, taste change, decreased appetite, dry mouth, or hypersalivation .
- Allergic reactions: skin rash, urticaria, myalgia, arthralgia, fever.
- From the genitourinary system: urinary incontinence or retention, dysmenorrhea, vaginitis, decreased libido, impaired sexual function in men (slowing of ejaculation).
- Other: increased sweating, tachycardia, violation visual acuity, weight loss, systemic disorders of the lungs, kidneys or liver, vasculitis.
Flunisan (Fluoxetine) 20mg with simultaneous application increases the effects of alprazolam, diazepam, ethanol and hypoglycemic drugs. With simultaneous application with Flunisan, the concentration of phenytoin, tricyclic antidepressants, maprotiline, trazodone is increased by a factor of 2 (it is necessary to reduce the dose of tricyclic antidepressants by 50% with simultaneous application).
Against the background of electroconvulsive therapy with simultaneous application with Flunisan (Fluoxetine) 20mg possible development prolonged epileptic seizures.
With simultaneous application with Flunisan, an increase in the concentration of lithium is possible, the risk of toxic effects of lithium increases, and frequent determination of the concentration of lithium in serum is recommended.
Tryptophan enhances the serotonergic properties of fluoxetine (increased agitation, motor anxiety, gastrointestinal disorders).
MAO inhibitors with simultaneous application with Flunisan (Fluoxetine) 20mg increase the risk of developing serotonin syndrome (hyperthermia, chills, increased sweating, myoclonus, hyperreflexia, tremor, diarrhea, movement coordination disorders, autonomic lability, agitation, nonsense and coma).
Drugs that exert a depressing effect on the central nervous system, while using with Flunisan (Fluoxetine) 20mg increase the risk of side effects and intensifying the inhibitory effect on the central nervous system.
With the simultaneous use of Flunisan with drugs that have a high degree of binding to proteins, especially with anticoagulants and digitoxin, it is possible to increase plasma concentrations of free (unbound) drugs and increase the risk of developing adverse effects.
Store Flunisan (Fluoxetine) 20mg at room temperature between 68-77 degrees F (20-25 degrees C) away from light and moisture. Do not store the drugs in the bathroom. Keep all drugs away from reach of children and pets.